SAP completes $1.5bn WalkMe acquisition, enhancing digital adoption capabilities

SAP completes $1.5bn WalkMe acquisition, enhancing digital adoption capabilities

SAP SE (NYSE: SAP) announced the successful completion of its acquisition of WalkMe Ltd., a company renowned for its digital adoption platform (DAP) technology. WalkMe Ltd., listed on the Nasdaq Global Select Market (NASDAQ: WKME), has now been integrated into SAP’s operations in a move designed to strengthen its ability to streamline digital transformation processes […]

Achilles Therapeutics shares skyrocket 32% after massive cost cuts—Is this the turnaround it needs?

Achilles Therapeutics shares skyrocket 32% after massive cost cuts—Is this the turnaround it needs?

Achilles Therapeutics PLC saw its American Depositary Receipts (ADRs) soar by an impressive 32%, reflecting renewed investor optimism following the company’s recent announcement of stringent cost-cutting measures. This move, which comes at a time of financial strain for many biotech companies, highlights Achilles’ commitment to securing its financial future while advancing its cutting-edge cancer therapies. […]

Netcapital shares plunge on 91% revenue decline in first quarter 2025

Netcapital shares plunge on 91% revenue decline in first quarter 2025

Shares of Netcapital Inc., a digital private capital markets ecosystem, nosedived after the company reported a dramatic 91% fall in revenue for the first quarter of fiscal year 2025. The Boston-based fintech firm’s revenue plummeted to $142,227 from $1.52 million in the same period the previous year, triggering a wave of concern among investors and […]

Exicure’s stock explodes 78% overnight – but is the comeback for real?

Exicure’s stock explodes 78% overnight – but is the comeback for real?

Shares of biopharmaceutical company Exicure Inc. skyrocketed by 78% in after-hours trading, closing at $2.84. The surge came after Exicure announced a significant debt-for-equity exchange with two holders of promissory notes. This financial maneuver aims to stabilise the company’s precarious financial standing amid growing uncertainties. Exicure converts debt to equity amid financial turmoil Exicure Inc., […]

Centessa Pharmaceuticals pulls off massive $225m deal—Stock price jumps

Centessa Pharmaceuticals pulls off massive $225m deal—Stock price jumps

Centessa Pharmaceuticals has experienced a substantial rise in its share price after completing an upsized public offering of American Depositary Shares (ADSs). The company, listed on Nasdaq, announced on 12 September 2024 that it successfully priced 15,254,237 ADSs at $14.75 per share, generating gross proceeds of approximately $225 million. This announcement has sparked considerable market […]

Lovesac stock skyrockets 25% – Is this the next big retail sensation?

Lovesac stock skyrockets 25% – Is this the next big retail sensation?

Lovesac, the innovative home furnishing company known for its unique modular furniture, saw its shares soar by 25% following the release of its second-quarter fiscal 2025 earnings report. The company’s unexpected performance, which outpaced market expectations, provided a positive jolt to its stock price, driven by a strategic blend of innovation, cost management, and forward-looking […]

ConnectOne Bancorp to merge with The First of Long Island to create $14bn bank

ConnectOne Bancorp to merge with The First of Long Island to create $14bn bank

ConnectOne Bancorp, Inc. (Nasdaq: CNOB), the parent company of ConnectOne Bank, announced a definitive merger agreement with The First of Long Island Corporation (Nasdaq: FLIC), the parent company of The First National Bank of Long Island. This merger will enable ConnectOne Bancorp to significantly expand its footprint on Long Island and the greater New York […]

Shoe Carnival shares explode 13%! Discover how back-to-school sales sparked this rally

Shoe Carnival shares explode 13%! Discover how back-to-school sales sparked this rally

Shares of Shoe Carnival Inc. jumped 13% to $42.64 in recent trading after the company reported blockbuster second-quarter earnings for fiscal 2024, driven by a surge in back-to-school sales and a strong performance across key product categories. The stock has almost doubled over the past 52 weeks, reflecting strong investor confidence in the company’s strategic […]

Biopharma shake-up: Semnur Pharmaceuticals to merge with Denali Capital in $2.5bn deal

Biopharma shake-up: Semnur Pharmaceuticals to merge with Denali Capital in $2.5bn deal

In a significant development within the biopharmaceutical industry, Semnur Pharmaceuticals, Inc. (“Semnur”), a wholly owned subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. (Nasdaq: DECA, “Denali”), a special purpose acquisition company (SPAC), have announced a definitive merger agreement. This proposed business combination is set to value Semnur at approximately $2.5 […]